Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Batenhorst

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Chest|November 1, 1988
Near-total reduction in verapamil bioavailability by rifampin. Electrocardiographic correlatesR A Barbarash, J L Bauman, J H Fischer, et al.
Annals of Internal Medicine|September 1, 1983
Patient-controlled analgesiaD A Graves, T S Foster, R L Batenhorst, et al.
American Journal of Hospital Pharmacy|October 1, 1984
Nifedipine stability in cardioplegic solutionM B Bottorff, D A Graves, R G McAllister, et al.
Drug Intelligence & Clinical Pharmacy|April 1, 1986
Patient-controlled analgesia in the terminally ill cancer patientT J Baumann, R L Batenhorst, D A Graves, et al.
American Journal of Hospital Pharmacy|November 1, 1985
Evaluation of 516 cardiopulmonary resuscitation attemptsR L Batenhorst, G D Clifton, D C Booth, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 1, 1990
MK-927: a topical carbonic anhydrase inhibitor. Dose response and duration of actionE J Higginbotham, M A Kass, E A Lippa, et al.
Archives of Dermatology|May 1, 1993
Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Acyclovir Study GroupL H Goldberg, R Kaufman, T O Kurtz, et al.
Clinical Pharmacy|January 1, 1983
Morphine requirements using patient-controlled analgesia: influence of diurnal variation and morbid obesityD A Graves, R L Batenhorst, R L Bennett, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Pharmacologic evaluation of loratadine (SCH 29851), chlorpheniramine and placeboR L Batenhorst, A S Batenhorst, D A Graves, et al.
Journal of Medical Virology|January 1, 1993
Continuous five-year treatment of patients with frequently recurring genital herpes simplex virus infection with acyclovirL H Goldberg, R H Kaufman, T O Kurtz, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Chest|November 1, 1988
Near-total reduction in verapamil bioavailability by rifampin. Electrocardiographic correlatesR A Barbarash, J L Bauman, J H Fischer, et al.
Annals of Internal Medicine|September 1, 1983
Patient-controlled analgesiaD A Graves, T S Foster, R L Batenhorst, et al.
American Journal of Hospital Pharmacy|October 1, 1984
Nifedipine stability in cardioplegic solutionM B Bottorff, D A Graves, R G McAllister, et al.
Drug Intelligence & Clinical Pharmacy|April 1, 1986
Patient-controlled analgesia in the terminally ill cancer patientT J Baumann, R L Batenhorst, D A Graves, et al.
American Journal of Hospital Pharmacy|November 1, 1985
Evaluation of 516 cardiopulmonary resuscitation attemptsR L Batenhorst, G D Clifton, D C Booth, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 1, 1990
MK-927: a topical carbonic anhydrase inhibitor. Dose response and duration of actionE J Higginbotham, M A Kass, E A Lippa, et al.
Archives of Dermatology|May 1, 1993
Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Acyclovir Study GroupL H Goldberg, R Kaufman, T O Kurtz, et al.
Clinical Pharmacy|January 1, 1983
Morphine requirements using patient-controlled analgesia: influence of diurnal variation and morbid obesityD A Graves, R L Batenhorst, R L Bennett, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Pharmacologic evaluation of loratadine (SCH 29851), chlorpheniramine and placeboR L Batenhorst, A S Batenhorst, D A Graves, et al.
Journal of Medical Virology|January 1, 1993
Continuous five-year treatment of patients with frequently recurring genital herpes simplex virus infection with acyclovirL H Goldberg, R H Kaufman, T O Kurtz, et al.
Pageof 3